SE9704451D0 - New method and compositions for the treatment of autoimmune diseases - Google Patents

New method and compositions for the treatment of autoimmune diseases

Info

Publication number
SE9704451D0
SE9704451D0 SE9704451A SE9704451A SE9704451D0 SE 9704451 D0 SE9704451 D0 SE 9704451D0 SE 9704451 A SE9704451 A SE 9704451A SE 9704451 A SE9704451 A SE 9704451A SE 9704451 D0 SE9704451 D0 SE 9704451D0
Authority
SE
Sweden
Prior art keywords
treatment
autoimmune diseases
new method
compositions
balancing
Prior art date
Application number
SE9704451A
Other languages
English (en)
Inventor
Anders Essen-Moeller
Original Assignee
Diamyd Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diamyd Therapeutics Ab filed Critical Diamyd Therapeutics Ab
Priority to SE9704451A priority Critical patent/SE9704451D0/sv
Publication of SE9704451D0 publication Critical patent/SE9704451D0/sv
Priority to AU15803/99A priority patent/AU1580399A/en
Priority to PCT/SE1998/002154 priority patent/WO1999027956A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
SE9704451A 1997-11-28 1997-11-28 New method and compositions for the treatment of autoimmune diseases SE9704451D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9704451A SE9704451D0 (sv) 1997-11-28 1997-11-28 New method and compositions for the treatment of autoimmune diseases
AU15803/99A AU1580399A (en) 1997-11-28 1998-11-27 Tolerance inducing combination of at least two endogenous antigens for treatmentof sms, sle, iddm, etc.
PCT/SE1998/002154 WO1999027956A1 (en) 1997-11-28 1998-11-27 Tolerance inducing combination of at least two endogenous antigens for treatment of sms, sle, iddm, etc.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704451A SE9704451D0 (sv) 1997-11-28 1997-11-28 New method and compositions for the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
SE9704451D0 true SE9704451D0 (sv) 1997-11-28

Family

ID=20409200

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704451A SE9704451D0 (sv) 1997-11-28 1997-11-28 New method and compositions for the treatment of autoimmune diseases

Country Status (3)

Country Link
AU (1) AU1580399A (sv)
SE (1) SE9704451D0 (sv)
WO (1) WO1999027956A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019112996A1 (en) * 2017-12-04 2019-06-13 Oklahoma Medical Research Foundation Method and compositions for treating obesity and insulin resistance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
EP1849870A1 (en) * 1995-02-20 2007-10-31 The Walter And Eliza Hall Institute Of Medical Research Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (IDDM)
AU6896396A (en) * 1995-08-11 1997-03-12 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Materials and methods for detection and treatment of insulin-dependent diabetes

Also Published As

Publication number Publication date
WO1999027956A1 (en) 1999-06-10
AU1580399A (en) 1999-06-16

Similar Documents

Publication Publication Date Title
ZA913282B (en) Dosage form
MD970199A (en) Induction of a cytotoxic T-lymphocytic answer The invention relates to the medicine, particularly to the immunology and can be used for treatment of bacterial and parasitic infections, tumors and other diseases. The summary of the invention consists in the induction of a cytotoxic T-lymphocytic answer to human and animals by means of a composition consisting of an antigene and an antigenic formulati
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
EP0637239A4 (en) METHOD FOR PROMOTING NITROGEN RETENTION IN PEOPLE.
EP1019072A4 (en) ASSISTANCE PROCESS FOR DIFFERENTIAL DIAGNOSIS AND TREATMENT OF AUTISM SYNDROME
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
HU9300636D0 (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
KR950701350A (ko) 부작용 감소와 동시에 인터페론을 이용한 질환의 치료방법 및 조성물(methods and compositions for the treatment of diseases with interferon while reducing side effects)
GEP20022783B (en) Method of Preventing and Delaying Onset of Alzheimer's Disease and Composition Therefor
EP0377520A3 (en) Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
BR9815255A (pt) Toxina de botulismo modificada, vacina oralcontra o botulismo, vacina oral contra umantìgeno selecionado e método para ministraroralmente um agente terapêutico a um animal
IL161889A0 (en) Method for treating diseases with omega interferon
HK1041215A1 (en) Use of thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir in manufacturing pharmaceutical combination preparations for treating hepatitis b infection.
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
JP2000178203A5 (sv)
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
GB9617611D0 (en) Treatment of autoimmune disease
CN2305177Y (zh) 按摩医疗保健支撑腰围
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
MD1469G2 (ro) Metodă de tratament al şocului combustional
BG49742A1 (en) Affrodisiance means
RU94020964A (ru) Электростатический пластырь "элпласт"